Bon Natural Life shares surge 10.29% premarket after unveiling kombucha-inspired beverage and $12M Greater China distribution deal with Qingshengyuan.
ByAinvest
Thursday, Dec 11, 2025 4:00 am ET1min read
BON--
Bon Natural Life (BON) surged 10.29% in premarket trading following the announcement of a kombucha-inspired tea-pigment beverage and a $12 million, 24-month non-exclusive sales agreement with Shaanxi Qingshengyuan across Greater China. The product, utilizing a SCOBY fermentation process to enhance tea pigment concentration, targets a $1 billion market opportunity for functional beverages. The partnership aims to expand BON’s commercialization and market awareness in the region, positioning the company to capitalize on growing demand for health-focused drinks. The news directly aligns with the stock’s upward movement, reflecting investor optimism over revenue growth potential and strategic market expansion.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet